We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Hinterview is a technology entity that has come up with a video platform that enables professional recruiters to engage and communicate more effectively with their target audience. The company believes that 'remote is the future of work', accelerated by COVID-19, that will drive more interest in their technology. The company asserts that its technology can aid agency, in-house or even college & campus recruitment drives producing satisfactory engagements between recruiters and job seekers. The company is white-labelled, ultra-secure, and cloud-based with General Data Protection Regulation (GDPR) compliance providing data privacy & security protocols to its clients. The company has 61,000 users active on its platform with 230+ active contracts. It will use the investment to further develop its sales and marketing functions and build departments internally as its business scales both in European and global markets.

Pitch Rated

45%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £421,505
Car Trust are a newly launched website backed by a comprehensive strategic plan and a motivated team. Users are able to buy and sell vehicles privately using the secure FCA authorised platform. Funds are being raised for marketing and product development.
days to go: Expired investment: £22,750
Brompton's bicycle hire allows people to hire folding bicycles from hiring stations. The hiring stations (docks) are sold to partners. The company have already sold 44 docks to partners. They are looking for investment to prepare the business for international expansion. The funding will used to increase the size of their network by placing more docks in strategic locations.  Their service will also be developed with the funds, working on their customer service and developing their skills.
days to go: Expired investment: £380,000
Clin-e-cal is a medical technology company that has created a 'Clip-Tone Buddy' app. The app uses Clin-e-cal's patented Sound Response (SR) technology to give real-time feedback helping patients understand how to use their inhalers correctly. The company intends to become a disruptor in the estimated £300 million inhaler technology market. It asserts that its app can help streamline clinical trials, identify patients most at risk and impact future respiratory device design. Clin-e-cal was short-listed for the Tech4Good award 2020 and rated 79% by The Organisation for the Review of Care and Health Applications (ORCHA). Clin-e-cal will use the investment to progress commercialisation of the Clip-Tone Buddy, scale its sales activity, and optimise the company's marketing, regulatory and legal aspects.

Pitch Rated

71%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £132,354
Metrion Biosciences is a pharmaceutical research organisation that provide a high quality drug discovery services for ion channel targets to clients on a fee-for-service or collaboration basis.
days to go: Expired investment: £465,150
Superpow! is an online therapy platform that intends to shift away from the conventional and clinical form of mental health treatment. It is a platform that aims to help users find a matching therapist based on factors such as preferred language, ethnical background, sexual orientation, gender, age, symptoms. The app endeavours to match a user with a therapist quicker than any other app. The company estimates that 70 million workdays are lost each year due to mental health problems in the UK, costing employers approximately £2.4 billion per year. This scenario is further exacerbated due to COVID-19. Superpow! aims to change this situation. It will use the investment to finalise app development, scale the business within the UK as well as Europe, and enter the US market.

Pitch Rated

42%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £59,613
Amplify Music, in association with the Music Managers Forum (MMF), provides UK tax paying investors with the opportunity to invest in the future careers of new and emerging music artists while benefiting from the significant tax advantages available through SEIS. MMF was established in 1992 and is now the largest representative body of artist managers in the world. MMF has over 400 members in the UK and represents over 1,000 of the world’s most successful acts.
days to go: Expired investment: Withheld
4solo comply tag enables organisations to automatically record work on properties helping them to keep compliant with all regulations.  They have created smart tags which can be applied to appliances/properties and used alongside their app to track contractors when doing maintenance to properties.  The investment will go towards sales, staff and marketing. (EIS Pending)
days to go: Expired investment: £40,990
The first solution to implement precision physiological monitoring into a compact earpiece, providing real-time data and powerful cloud-based analytics that simplify and automate the monitoring of athletes, military personnel and industrial workforces.
days to go: Expired investment: £818,943
Luas Diagnostics (LD) aims to develop and market easy-to-use, rapid and accurate diagnostics tests with the aim of deploying these tests in remote settings away from centralised testing laboratories. The company has signed an exclusive distribution agreement with Chembio Diagnostics Systems (CDS) in the USA to market its Covid-19 antibody and antigen tests in the UK and Ireland. It has also signed a Memorandum of Understanding (MoU) with the University of Birmingham to develop saliva-based, rapid Covid-19 tests. LD is also working on coming up with a therapeutic drug monitoring system based on the same technology used worldwide to test people with diabetes for glucose levels in the blood. The company is developing the system so that it can be used at home, in pharmacies or GP surgery. The first product will test for Theophylline which is used to treat Chronic Obstructive Pulmonary Disease (COPD). LD will use the investment to grow its business across different verticals.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £326,190
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph